June 03 – 04, 2024

euroPLX 85 Dublin

Midas Pharma is developing business opportunities worldwide. At euroPLX 85, we want to focus on out-licensing of our FDF-Portfolio.

Midas offers generic specialty and niche products, including but not limited to new combination products as well as traditional generic developments. In addition to its own product pipeline, Midas provides access to registration dossiers and development services.

In particular, Midas is able to assist from the idea stage of contract drug development.

Meet us and discuss licensing opportunities with our experts!

 

Your Contact

Andreas Kahm

Andreas Kahm

Business Development
Senior Manager

Midas Pharma GmbH
Rheinstr. 49
55218 Ingelheim
Germany
Send E-Mail

Share this page